| AUC | area under the plasma drug concentration-t curve |
| β-CD | β-cyclodextrin |
| Brij 78 or Brij S20 | polyoxyethylene 20 stearyl ether |
| BS | Bile Salts |
| Cmax | maximum plasma drug concentration |
| CA | Caprylic Acid |
| Capryol 90 | propylene glycol monocaprylate |
| CHOL | cholesterol |
| CMCHS | carboxymethylchitosan |
| CP | cetyl palmitate |
| Cremophor® EL | polyoxy-35-castor oil |
| Cremophor® RH40 | polyoxyl 40 hydrogenated castor oil |
| DCP | dicetylphosphate |
| DDs | Drug Delivery Systems |
| D-GaIN | D-galactosamine |
| DON | Deoxynivalenol |
| DPPC | DiPalmitoylPhosphatidylCholine |
| DSPE | DiStearoylPhosphatidylEthanolamine |
| EE | Entrapment Efficiency |
| EES | Emulsification Evaporation Solidification |
| ESD | Emulsification/Solvent Diffusion |
| ESE | Emulsification/Solvent Evaporation |
| EVO | extra virgin olive |
| GA | glycyrrhizic acid |
| GDS | GlycerylDiStearate |
| Geleol® | mono-, di- and triesters of palmitic and stearic acids |
| GIT | gastrointestinal tract |
| GMO | GlycerylMonoOleate |
| GMS | GlycerylMonoStearate |
| HCO-X® | PEG-X Hydrogenated Castor Oil, (X = 40, 50) |
| HP-β-CD | 2-hydroxypropyl-β-cyclodextrin |
| HPH | High Pressure Homogenization |
| HPMC (E50LV) | HydroxyPropyl MethylCellulose |
| HSPC | Soya Hydrogenated L-α-PhosphatidylCholine |
| i.p. | intraperitoneal |
| IPM (Estol) | isopropyl myristate |
| isoSIL | isosilybin |
| i.v. | intravenous |
| Labrafac® CC | Medium Chain Triglycerides (MCT) |
| Labrafil® | transesterified ethoxylated vegetable oils |
| Labrasol® | caprylocaproyl polyoxylglycerides (macrogolglycerides) |
| MCT | Medium chain triglycerides |
| NaCMC | Sodium CarboxyMethylCellulose |
| NAFLD | NonAlcoholic Fatty Liver Disease |
| NLCs | Nanostructured Lipid Carriers |
| NPs | nanoparticles |
| OA | oleic acid |
| P188 | Poloxamer 188 |
| P407 | Poloxamer 407 |
| PAMAM | polyamidoamine |
| PC | L-α-PhosphatidylCholine |
| PCL | poly-ε-caprolactone |
| PDI | polydispersity index |
| PEG | polyethyleneglycol |
| PGA | poly-γ-glutamic acid |
| PLGA | poly(d,l-lactic-co-glycolic acid) |
| PPC | Polyene PhosphatidylCholine |
| Precirol® ATO 5 | Glyceryl distearate/palmitostearate |
| PVA | Polyvinyl alcohol |
| PVP | polyvinylpyrrolidone |
| RAMEB | randomly methylated-β-cyclodextrin |
| RPE | reverse phase evaporation |
| SA | stearic acid |
| SC | Sodium Cholate |
| SCF-CO2 | SuperCritical Fluid of carbon dioxide |
| SDC | Sodium DeoxyCholate |
| SEDS | Solution-Enhanced Dispersion Supercritical fluids |
| SEDDS | Self Emulsifying Drug Delivery System |
| Sefsol® 218 | propylene glycol monocaprylic ester |
| SGC | Sodium GlycoCholate |
| SGF/SIF | simulated gastric fluid (pH 1.2)/simulated intestinal fluid (pH 7.4) |
| SIL | Silybin or silybinin |
| SILcr | silycristin |
| SILdi | silydianin |
| Sito-G | β-sitosterol β-d-glucoside |
| SLM | silymarin extract |
| SLNs | Solid Lipid Nanoparticles |
| SLS | Sodium Lauryl Sulfate |
| Solutol® HS 15 | PEG (15)-hydroxystearate |
| SPC | Soya L-α-PhosphatidylCholine |
| SPG | Shirasu Porous Glass membrane emulsification |
| SPMM | Na cholate/phospholipid mixed micelles |
| STC | Sodium TauroCholate |
| SUV | small unilamellar vesicles |
| TFD | Thin-Film Dispersion |
| TNF-α | Tumour Necrosis Factor-α |
| TPGS | D-α-Tocopheryl PEG 1000 Succinate |
| TPP | TriPolyPhosphate |
| Transcutol® | diethylene glycol monoethyl ether |
| Triacetin | glycerol triacetate |
| Tween 20 | polyoxyethylene sorbitan monolaurate (polysorbate 20) |
| Tween 80 | polyoxyethylene sorbitan monooleate (polysorbate 80) |
| TXF | taxifolin |